KK4277
/ SBI Biotech, Kyowa Kirin
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 19, 2024
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=157 | Recruiting | Sponsor: Kyowa Kirin Co., Ltd. | N=116 ➔ 157 | Trial completion date: Mar 2025 ➔ Dec 2025
Enrollment change • Trial completion date • Cutaneous Lupus Erythematosus • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
August 08, 2023
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus
(clinicaltrials.gov)
- P1 | N=116 | Recruiting | Sponsor: Kyowa Kirin Co., Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: Sep 2024 ➔ Mar 2025 | Trial primary completion date: Sep 2023 ➔ Dec 2024
Enrollment open • Trial completion date • Trial primary completion date • Cutaneous Lupus Erythematosus • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
October 04, 2017
Newly added pipeline product: SBI-9674
(SBI Biotech Press Release)
Pipeline update • Lupus
1 to 3
Of
3
Go to page
1